This animal model study investigated whether pretreatment with methylene blue could reduce seizures and associated brain damage in rats subjected to repeated seizure induction via pentylenetetrazole. Researchers found that methylene blue pretreatment attenuated seizure severity, prevented cognitive impairment, reduced hippocampal neuronal damage, and decreased oxidative stress markers compared to untreated seizure-prone rats. This is an animal model study with potential translational relevance, though findings require further investigation in human clinical populations before any clinical applications can be considered.